Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma

Journal of Pathology

Volumn 226, Issue 3, 2012, Pages 471-481

  Man, Cheuk Him ^a   Wei Man Lun, Samantha ^a   Hui, Jan Wai Ying ^a,b   To, Ka Fai ^a   Choy, Kwong Wai ^a   Wing Hung Chan, Anthony ^a   Chow, Chit ^a   Tin Yun Chung, Grace ^a   Tsao, Sai Wah ^c   Tak Chun Yip, Timothy ^d   Busson, Pierre ^e   Lo, Kwok Wai ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^e INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

cisplatin; Epstein Barr virus; nasopharyngeal carcinoma; NOTCH3

Indexed keywords

CISPLATIN; NOTCH3 RECEPTOR; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPHEROID CELL; TUMOR CELL LINE; UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CISPLATIN; EPSTEIN-BARR VIRUS INFECTIONS; GENE KNOCKDOWN TECHNIQUES; GENES, NEOPLASM; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICE; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM TRANSPLANTATION; RECEPTORS, NOTCH; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84856057486     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2997     Document Type: Article

References (32)

1. Lo KW, To KF, Huang DP,. Focus on nasopharyngeal carcinoma. Cancer Cell 2004; 5: 423-428. (Pubitemid 38612865)
2. Razak AR, Siu LL, Liu FF, et al., Nasopharyngeal carcinoma: the next challenges. Eur J Cancer 2010; 4: 1967-1978.
3. Hui ABY, Or YY, Takano H, et al., Array-based CGH analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma. Cancer Res 2005; 65: 8125-8133. (Pubitemid 41330575)
4. Or YY, Chung GT, To KF, et al., Identification of a novel 12p13.3 amplicon in nasopharyngeal carcinoma. J Pathol 2010; 220: 97-107.
5. Rizzo P, Osipo C, Foreman K, et al., Rational targeting of Notch signaling in cancer. Oncogene 2008; 27: 5124-5131.
6. Grabher C, von Boehmer H, Look AT,. Notch1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 2006; 6: 347-359.
7. Koch U, Radtke F,. Notch signaling in solid tumors. Curr Top Dev Biol 2010; 92: 411-455.
8. Park JT, Li M, Nakayama K, et al., Notch3 gene amplification in ovarian cancer. Cancer Res 2006; 66: 6312-6318.
9. Puente XS, Pinyol M, Quesada V, et al., Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011; 475: 101-105.
10. Cheung ST, Huang DP, Hui ABY, et al., (1999). Nasopharyngeal carcinoma cell line (C666-1) consistently harboring Epstein-Barr virus. Int J Cancer 1999; 83: 121-126. (Pubitemid 29409487)
11. Huang DP, Ho JH, Poon YF, et al., Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx. Int J Cancer 1980; 26: 127-132. (Pubitemid 10086410)
12. Huang DP, Ho JH, Chan WK, et al., Cytogenetics of undifferentiated nasopharyngeal carcinoma xenografts from southern Chinese. Int J Cancer 1989; 43: 936-939. (Pubitemid 19138209)
13. Busson P, Ganem G, Flores P, et al., Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int J Cancer 1988; 42: 599-606. (Pubitemid 18264074)
14. Tsao SW, Wang X, Liu Y, et al., Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim Biophys Acta 2002; 1590: 150-158. (Pubitemid 34626778)
15. Tong JH, Ng DC, Chau SL, et al., Putative tumor-suppressor gene DAB2 is frequently down-regulated by promoter hypermethylation in nasopharyngeal carcinoma. BMC Cancer 2010; 10: 253.
16. Chow LS, Lo KW, Kwong J, et al., RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma. Int J Cancer 2004; 109: 839-847. (Pubitemid 38500740)
17. Pece S, Serresi M, Santolini E, et al., Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol 2004; 167: 215-221. (Pubitemid 39435065)
18. Stylianou S, Clarke RB, Brennan K,. Aberrant activation of notch signaling in human breast cancer. Cancer Res 2006; 66: 1517-1525. (Pubitemid 43259933)
19. Anderson LJ, Longnecker R,. An auto-regulatory loop for EBV LMP2A involves activation of Notch. Virology 2008; 371: 257-266. (Pubitemid 351173234)
20. Yamaguchi N, Oyama T, Ito E, et al., NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells. Cancer Res 2008; 68: 1881-1888. (Pubitemid 351416574)
21. Konishi J, Kawaguchi KS, Vo H, et al., Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. Cancer Res 2007; 67: 8051-8057. (Pubitemid 47395139)
22. Lu QL, Elia G, Lucas S, et al., Bcl-2 proto-oncogene expression in Epstein-Barr virus-associated nasopharyngeal carcinoma. Int J Cancer 1993; 53: 29-35. (Pubitemid 23018418)
23. Yip KW, Shi W, Pintilie M, et al., Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Clin Cancer Res 2006; 12: 5726-5732. (Pubitemid 44629602)
24. Porter MJ, Field JK, Leung SF, et al., The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. Acta Otolaryngol 1994; 114: 105-109. (Pubitemid 24009244)
25. Khabir A, Ghorbel A, Daoud J, et al., Similar BCL-X but different BCL-2 levels in the two age groups of north African nasopharyngeal carcinomas. Cancer Detect Prev 2003; 27: 250-255. (Pubitemid 36990242)
26. Thornburg NJ, Pathmanathan R, Raab-Traub N,. Activation of nuclear factor-κB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma. Cancer Res 2003; 63: 8293-8301. (Pubitemid 37549481)
27. Ma BB, Hui EP, Chan AT,. Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions. Cancer Sci 2008; 99: 1311-1318. (Pubitemid 351761718)
28. Park JT, Chen X, Tropè CG, et al., Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin. Am J Pathol 2010; 177: 1087-1094.
29. Sullivan JP, Spinola M, Dodge M, et al., Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res 2010; 70: 9937-9948.
30. Wu Y, Cain-Hom C, Choy L, et al., Therapeutic antibody targeting of individual Notch receptors. Nature 2010; 464: 1052-1057.
31. Li K, Li Y, Wu W, et al., Modulation of Notch signaling by antibodies specific for the extracellular negative regulatory region of NOTCH3. J Biol Chem 2008; 283: 8046-8054.
32. Lin L, Mernaugh R, Yi F, et al., Targeting specific regions of the Notch3 ligand-binding domain induces apoptosis and inhibits tumor growth in lung cancer. Cancer Res 2010; 70: 632-638.